1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico);Lancet,1986
2. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity, and infarct size at 21 days;ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study Group;N Engl J Med,1986
3. Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial;AIMS (APSAC Intervention Mortality Study) Trial Study Group;Lancet,1988
4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988
5. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction (ASSET);Wilcox;Lancet,1988